Literature DB >> 12869142

Increased production of interferon-gamma by Leishmania homologue of the mammalian receptor for activated C kinase-reactive CD4+ T cells among human blood mononuclear cells: an early marker of exposure to Leishmania?

E Bourreau1, H Pascalis, G Prévot, A Kariminia, N Jolly, G Milon, P Buffet, R Michel, J-B Meynard, J-P Boutin, D Aschimoff, P Launois.   

Abstract

A prospective study was undertaken to define early predictive immunological marker(s) of exposure to Leishmania in naïve subjects who have never been exposed to any Leishmania and who were also free of any cutaneous leishmaniasis lesions. These naïve subjects could have been exposed to Leishmania in a rain forest where Leishmania guyanensis and their natural vectors and mammalian host are cocirculating. The production of interferon (IFN)-gamma in response to the Leishmania homologue of the mammalian receptor for activated c kinase (LACK), a candidate for vaccine against leishmaniasis was analysed. At the end of their stay in the rain forest, LACK-specific CD8+ T cells were detected in subjects whose peripheral blood mononuclear cell (PBMC) produced IFN-gamma in response to soluble Leishmania antigens (SLA) and in those whose PBMC remained unresponsive to SLA. However, LACK-specific CD4+ T cells were detected only in PBMCs from individuals who became IFN-gamma responders to SLA. In subjects whose PBMC became positive to SLA, LACK-reactive CD4+ T cells producing high level of IFN-gamma were detectable before the SLA-reactive IFN-gamma producing CD4+ T cells, suggesting that the former readout assay could be used as an early predictive immunological marker of exposure to Leishmania in subjects who remained disease free.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12869142     DOI: 10.1046/j.1365-3083.2003.01280.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  4 in total

1.  Transforming growth factor beta 1 production by CD4+ CD25+ regulatory T cells in peripheral blood mononuclear cells from healthy subjects stimulated with Leishmania guyanensis.

Authors:  A Kariminia; E Bourreau; H Pascalis; P Couppié; D Sainte-Marie; F Tacchini-Cottier; P Launois
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Leishmania major large RAB GTPase is highly immunogenic in individuals immune to cutaneous and visceral leishmaniasis.

Authors:  Rym Chamakh-Ayari; Mehdi Chenik; Ahmed Sahbi Chakroun; Narges Bahi-Jaber; Karim Aoun; Amel Meddeb-Garnaoui
Journal:  Parasit Vectors       Date:  2017-04-17       Impact factor: 3.876

3.  Analysis of the Antigenic and Prophylactic Properties of the Leishmania Translation Initiation Factors eIF2 and eIF2B in Natural and Experimental Leishmaniasis.

Authors:  Esther Garde; Laura Ramírez; Laura Corvo; José C Solana; M Elena Martín; Víctor M González; Carlos Gómez-Nieto; Aldina Barral; Manoel Barral-Netto; José M Requena; Salvador Iborra; Manuel Soto
Journal:  Front Cell Infect Microbiol       Date:  2018-04-05       Impact factor: 5.293

4.  Antigenicity of Leishmania-Activated C-Kinase Antigen (LACK) in Human Peripheral Blood Mononuclear Cells, and Protective Effect of Prime-Boost Vaccination With pCI-neo-LACK Plus Attenuated LACK-Expressing Vaccinia Viruses in Hamsters.

Authors:  Laura Fernández; Eugenia Carrillo; Lucas Sánchez-Sampedro; Carmen Sánchez; Ana Victoria Ibarra-Meneses; M Angeles Jimenez; Valter Dos Anjos Almeida; Mariano Esteban; Javier Moreno
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.